Report Detail

Request for Sample of this report

Other Global Infectious Respiratory Disease Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4626420
    • |
  • 10 September, 2025
    • |
  • Global
    • |
  • 93 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Infectious Respiratory Disease Diagnostics market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Infectious Respiratory Disease Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Infectious Respiratory Disease Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Infectious Respiratory Disease Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Infectious Respiratory Disease Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Infectious Respiratory Disease Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infectious Respiratory Disease Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infectious Respiratory Disease Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., BioMerieux SA, Bio-Rad Laboratories, Inc., Quidel Corporation, Siemens Healthcare GmbH, Danaher, Qiagen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Infectious Respiratory Disease Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Instruments
Consumables
Services
Market segment by Application
COVID-19
Influenza
Respiratory Syncytial Virus (RSV)
Tuberculosis
Streptococcus Testing
Market segment by players, this report covers
Abbott
Thermo Fisher Scientific, Inc.
Koninklijke Philips N.V.
F. Hoffmann-La Roche Ltd.
BioMerieux SA
Bio-Rad Laboratories, Inc.
Quidel Corporation
Siemens Healthcare GmbH
Danaher
Qiagen
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infectious Respiratory Disease Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Respiratory Disease Diagnostics, with revenue, gross margin, and global market share of Infectious Respiratory Disease Diagnostics from 2020 to 2025.
Chapter 3, the Infectious Respiratory Disease Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Infectious Respiratory Disease Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Respiratory Disease Diagnostics.
Chapter 13, to describe Infectious Respiratory Disease Diagnostics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Infectious Respiratory Disease Diagnostics by Type
    • 1.3.1 Overview: Global Infectious Respiratory Disease Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Infectious Respiratory Disease Diagnostics Consumption Value Market Share by Type in 2024
    • 1.3.3 Instruments
    • 1.3.4 Consumables
    • 1.3.5 Services
  • 1.4 Global Infectious Respiratory Disease Diagnostics Market by Application
    • 1.4.1 Overview: Global Infectious Respiratory Disease Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 COVID-19
    • 1.4.3 Influenza
    • 1.4.4 Respiratory Syncytial Virus (RSV)
    • 1.4.5 Tuberculosis
    • 1.4.6 Streptococcus Testing
  • 1.5 Global Infectious Respiratory Disease Diagnostics Market Size & Forecast
  • 1.6 Global Infectious Respiratory Disease Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Infectious Respiratory Disease Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Infectious Respiratory Disease Diagnostics Market Size by Region, (2020-2031)
    • 1.6.3 North America Infectious Respiratory Disease Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Infectious Respiratory Disease Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Infectious Respiratory Disease Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.6 South America Infectious Respiratory Disease Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Infectious Respiratory Disease Diagnostics Product and Solutions
    • 2.1.4 Abbott Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Abbott Recent Developments and Future Plans
  • 2.2 Thermo Fisher Scientific, Inc.
    • 2.2.1 Thermo Fisher Scientific, Inc. Details
    • 2.2.2 Thermo Fisher Scientific, Inc. Major Business
    • 2.2.3 Thermo Fisher Scientific, Inc. Infectious Respiratory Disease Diagnostics Product and Solutions
    • 2.2.4 Thermo Fisher Scientific, Inc. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
  • 2.3 Koninklijke Philips N.V.
    • 2.3.1 Koninklijke Philips N.V. Details
    • 2.3.2 Koninklijke Philips N.V. Major Business
    • 2.3.3 Koninklijke Philips N.V. Infectious Respiratory Disease Diagnostics Product and Solutions
    • 2.3.4 Koninklijke Philips N.V. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Koninklijke Philips N.V. Recent Developments and Future Plans
  • 2.4 F. Hoffmann-La Roche Ltd.
    • 2.4.1 F. Hoffmann-La Roche Ltd. Details
    • 2.4.2 F. Hoffmann-La Roche Ltd. Major Business
    • 2.4.3 F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Product and Solutions
    • 2.4.4 F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
  • 2.5 BioMerieux SA
    • 2.5.1 BioMerieux SA Details
    • 2.5.2 BioMerieux SA Major Business
    • 2.5.3 BioMerieux SA Infectious Respiratory Disease Diagnostics Product and Solutions
    • 2.5.4 BioMerieux SA Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 BioMerieux SA Recent Developments and Future Plans
  • 2.6 Bio-Rad Laboratories, Inc.
    • 2.6.1 Bio-Rad Laboratories, Inc. Details
    • 2.6.2 Bio-Rad Laboratories, Inc. Major Business
    • 2.6.3 Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Product and Solutions
    • 2.6.4 Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
  • 2.7 Quidel Corporation
    • 2.7.1 Quidel Corporation Details
    • 2.7.2 Quidel Corporation Major Business
    • 2.7.3 Quidel Corporation Infectious Respiratory Disease Diagnostics Product and Solutions
    • 2.7.4 Quidel Corporation Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Quidel Corporation Recent Developments and Future Plans
  • 2.8 Siemens Healthcare GmbH
    • 2.8.1 Siemens Healthcare GmbH Details
    • 2.8.2 Siemens Healthcare GmbH Major Business
    • 2.8.3 Siemens Healthcare GmbH Infectious Respiratory Disease Diagnostics Product and Solutions
    • 2.8.4 Siemens Healthcare GmbH Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Siemens Healthcare GmbH Recent Developments and Future Plans
  • 2.9 Danaher
    • 2.9.1 Danaher Details
    • 2.9.2 Danaher Major Business
    • 2.9.3 Danaher Infectious Respiratory Disease Diagnostics Product and Solutions
    • 2.9.4 Danaher Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Danaher Recent Developments and Future Plans
  • 2.10 Qiagen
    • 2.10.1 Qiagen Details
    • 2.10.2 Qiagen Major Business
    • 2.10.3 Qiagen Infectious Respiratory Disease Diagnostics Product and Solutions
    • 2.10.4 Qiagen Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Qiagen Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Infectious Respiratory Disease Diagnostics Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Infectious Respiratory Disease Diagnostics by Company Revenue
    • 3.2.2 Top 3 Infectious Respiratory Disease Diagnostics Players Market Share in 2024
    • 3.2.3 Top 6 Infectious Respiratory Disease Diagnostics Players Market Share in 2024
  • 3.3 Infectious Respiratory Disease Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Infectious Respiratory Disease Diagnostics Market: Region Footprint
    • 3.3.2 Infectious Respiratory Disease Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Infectious Respiratory Disease Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Infectious Respiratory Disease Diagnostics Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Infectious Respiratory Disease Diagnostics Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Infectious Respiratory Disease Diagnostics Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Infectious Respiratory Disease Diagnostics Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Infectious Respiratory Disease Diagnostics Consumption Value by Type (2020-2031)
  • 6.2 North America Infectious Respiratory Disease Diagnostics Market Size by Application (2020-2031)
  • 6.3 North America Infectious Respiratory Disease Diagnostics Market Size by Country
    • 6.3.1 North America Infectious Respiratory Disease Diagnostics Consumption Value by Country (2020-2031)
    • 6.3.2 United States Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Infectious Respiratory Disease Diagnostics Consumption Value by Type (2020-2031)
  • 7.2 Europe Infectious Respiratory Disease Diagnostics Consumption Value by Application (2020-2031)
  • 7.3 Europe Infectious Respiratory Disease Diagnostics Market Size by Country
    • 7.3.1 Europe Infectious Respiratory Disease Diagnostics Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.3 France Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Infectious Respiratory Disease Diagnostics Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Infectious Respiratory Disease Diagnostics Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Infectious Respiratory Disease Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Infectious Respiratory Disease Diagnostics Consumption Value by Region (2020-2031)
    • 8.3.2 China Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.5 India Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Infectious Respiratory Disease Diagnostics Consumption Value by Type (2020-2031)
  • 9.2 South America Infectious Respiratory Disease Diagnostics Consumption Value by Application (2020-2031)
  • 9.3 South America Infectious Respiratory Disease Diagnostics Market Size by Country
    • 9.3.1 South America Infectious Respiratory Disease Diagnostics Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Infectious Respiratory Disease Diagnostics Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Infectious Respiratory Disease Diagnostics Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Infectious Respiratory Disease Diagnostics Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Infectious Respiratory Disease Diagnostics Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Infectious Respiratory Disease Diagnostics Market Drivers
  • 11.2 Infectious Respiratory Disease Diagnostics Market Restraints
  • 11.3 Infectious Respiratory Disease Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Infectious Respiratory Disease Diagnostics Industry Chain
  • 12.2 Infectious Respiratory Disease Diagnostics Upstream Analysis
  • 12.3 Infectious Respiratory Disease Diagnostics Midstream Analysis
  • 12.4 Infectious Respiratory Disease Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Infectious Respiratory Disease Diagnostics. Industry analysis & Market Report on Infectious Respiratory Disease Diagnostics is a syndicated market report, published as Global Infectious Respiratory Disease Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Infectious Respiratory Disease Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo